Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Wuhan Neurophth Biotechnology Limited Company

Clinical trials sponsored by Wuhan Neurophth Biotechnology Limited Company, explained in plain language.

Not yet finished but already full! 1

One-Shot gene injection aims to restore sight in genetic blindness trial

Disease control Ongoing

This study is testing whether a single injection of an experimental gene therapy (NR082) into the eye is safe and can improve vision in people with Leber's hereditary optic neuropathy (LHON), a genetic condition that causes vision loss. The trial will enroll about 95 people aged …

Phase: PHASE3 • Sponsor: Wuhan Neurophth Biotechnology Limited Company • Aim: Disease control

Last updated Apr 03, 2026 14:42 UTC